Recent Acquisition Fuels Global R&D Effort
Last year, Toshiba Medical Systems Corporation announced that via its newly formed, wholly-owned subsidiary, Toshiba Medical Visualization Systems Europe, Ltd. (TMVS), it would acquire the Advanced Visualization Imaging System Division (AVIS) of Barco nv, Edinburgh, Scotland. This acquisition was made complete last month.
This acquisition brings in-house critical core competencies — the development of 3D volume rendering and advanced visualization capabilities for all Toshiba modalities. In addition, Toshiba now is capable of conducting R&D twenty-four hours a day, seven days a week, ensuring that the medical community gets the most advanced technologies possible.
“The formation of TMVS establishes a significant multi-modality research and development center in Europe,” said Kenichi Komatsu Ph. D., president and CEO, Toshiba Medical, “ensuring Toshiba’s unfettered access to leading-edge technology in an area of the world widely acknowledged for its innovations in medicine. This also demonstrates Toshiba’s strong commitment to our customers in Europe as well as the healthcare industry worldwide.”
Toshiba is patterning this acquisition after the 2006 acquisition which resulted in the creation of Toshiba Medical Research Institute USA, Inc. (TMRU), a wholly–owned subsidiary. TMRU is a significant research and development center of advanced imaging technologies and clinical applications in the U.S. Combined with Toshiba’s R&D capabilities in Japan, the company undertakes development efforts worldwide on a 24-hour basis.
Toshiba’s global research entities support clinical programs in partnership with luminary academic institutions worldwide to accelerate research and development of clinical applications using Toshiba’s advanced imaging systems.
Tags: 3D Volume rendering, AVIS, education, Medical Imaging, research
Category: Future Technology —